Stress and Hypertension in Dementia Caregivers
MIM-DASH
Addressing the Double Jeopardy of Stress and Hypertension Among African American Female Caregivers of Persons Living With Alzheimer's Disease and Related Dementias
2 other identifiers
interventional
28
1 country
1
Brief Summary
No demographic group is more at risk for the double jeopardy of caregiving stress and hypertension (HTN) than African American women caring for a family member with Alzheimer's disease and related dementias (ADRD). Both situations lead to reduced quality of life and cardiovascular disease-a complication of uncontrolled hypertension. Maintaining the health of these caregivers is critical to support the well-being of the care recipients. Although some multi-component interventions have addressed ADRD caregiver's stress and quality of life, gaps remain in targeting interventions to address the complexity of chronic caregiving stress and hypertension self-care in African American women. This pilot study builds on the investigator's earlier work which showed that stress, blood pressure knowledge, and complex diet information deficits all interfered with older African American women's hypertension self-care. Lifestyle changes (stress management, reducing sodium, eating fruits/vegetables, and physical activity) are effective in managing hypertension. The investigator's Stage I pilot study is based on the scientific rationale that these lifestyle changes can be promoted by addressing stress reactivity/stress resilience, the psychological and physiological response of the body to stress, as the underlying mechanism to facilitate behavioral change. In this way the study can improve health outcomes (caregiver stress, quality of life, cardiovascular disease risk).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Jan 2023
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2022
CompletedStudy Start
First participant enrolled
January 17, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2024
CompletedResults Posted
Study results publicly available
February 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2025
CompletedSeptember 17, 2025
September 1, 2025
1.7 years
November 10, 2022
December 3, 2024
September 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Blood Pressure (Systolic)
Change is being assessed in systolic blood pressure measured with an automatic blood pressure cuff. Results outside of the normal range (90/60 to 120/80 mmHg), both higher and lower are considered undesirable.
Baseline, 3 months, 9 months
Change in Blood Pressure (Diastolic)
Change is being assessed in diastolic blood pressure measured with an automatic blood pressure cuff. Results outside of the normal range (90/60 to 120/80 mmHg), both higher and lower are considered undesirable.
Baseline, 3 month, 9 month
Change in Heart Rate
Change in heart rate is being assessed with an automatic blood pressure cuff. Results outside of the normal range (60 to 100 beats per minute), both higher and lower, are considered undesirable.
Baseline, 3 month, 9 month
Secondary Outcomes (10)
Newest Vital Sign
Baseline
Change is Being Assessed in Stress Management Practices Survey Part A
Baseline, 3 months, 9 months
Change is Being Assessed in Perceived Stress Scale (Caregiver Stress)
Baseline, 3 months, 9 months
Change is Being Assessed in in World Health Organization Quality of Life (WHO-5 QOL)
Baseline, 3 months, 9 months
Change is Being Assessed in Generalized Anxiety Symptom Scale
Baseline, 3 months, 9 months
- +5 more secondary outcomes
Study Arms (2)
MIM-DASH
EXPERIMENTALA trained MIM provider and dietitian will deliver the MIM DASH group intervention in eight weekly 1-hour sessions via telehealth.
Attention Control
NO INTERVENTIONA trained interventionist will deliver the Caregiver Training. Participants in this group will attend eight 1-hour group lessons via telehealth for 8 weeks. We will use Alzheimer's Association caregiver training resources on topics such as Healthy Living for Your Brain and Body: Tips from the Latest Research; Dementia Conversations: Driving, Doctors Visits, Legal and Financial Planning; and Understanding and Responding to Dementia-Related Behavior. Similar to the MIM DASH group, participants will receive educational materials so they can follow along using videoconferencing or phone.
Interventions
A trained MIM provider and dietitian will deliver the MIM DASH group intervention in eight weekly 1-hour sessions via telehealth. Participants will receive session materials so they can follow along. Each MIM session consists of material related to mindfulness-the somatic mind/body connection, relaxation, yoga, meditation, self-awareness, and bodily cues relating to emotional reactivity. Group interaction centers on sharing ideas toward effective practice and practical daily challenges to being mindful. Each class begins with a prompt for participant contemplation during the next hour that reference a unique weekly theme which will be reiterated in the session materials. The DASH portion, led by the Registered Dietitian, focuses on education to increase vegetables, fruits, whole grains and decrease intakes of fat and sodium, sugar sweetened beverages and sweets. Education includes adapting traditional "Soul" food dishes to meet the DASH dietary guidelines.
Eligibility Criteria
You may qualify if:
- diagnosis of Hypertension (HTN) treated with an antihypertensive medication;
- age 40 and older
- a caregiver rating of the People Living With Dementia (PLWD) of 2 or greater on the Alzheimer's Dementia-8 scale;
- caregiver provides unpaid care to a PLWD at least 10 hours per week or assists with at least one instrumental activity of daily living
- self-identifies as Black/African American;
- English speaking; and
- access to a telecommunications device such as the internet via desktop, laptop/tablet, smartphone, or telephone.
You may not qualify if:
- expect to move out of the area within 9 months;
- diagnosis of resistant HTN (blood pressure that remains above goal despite concurrent use of a diuretic/water pill and at least two other antihypertensive agents of different classes); or
- active participation in mindfulness/yoga program. The National Institute of Aging Common Data Screening and Enrollment forms will be used to track data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ohio State Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
College of Nursing Ohio State University
Columbus, Ohio, 43210, United States
Related Publications (1)
Wright KD, Richards Adams IK, Helsabeck NP, Rose KM, Moss KO, Nemati D, Palmer N, Kim B, Pokhrel Bhattarai S, Nguyen C, Addison D, Klatt MD. Stress and Hypertension Among African American Female Family Caregivers of Persons Living With Alzheimer Disease and Related Dementias: Protocol for a Pilot Internet-Based Randomized Controlled Trial. JMIR Res Protoc. 2025 Mar 27;14:e66975. doi: 10.2196/66975.
PMID: 40146982DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Kathy Wright
- Organization
- The Ohio State University College of Nursing
Study Officials
- PRINCIPAL INVESTIGATOR
Kathy Wright, PhD
Ohio State University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 10, 2022
First Posted
February 10, 2023
Study Start
January 17, 2023
Primary Completion
September 15, 2024
Study Completion
September 2, 2025
Last Updated
September 17, 2025
Results First Posted
February 12, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Individual participant data will not be shared due to the regulation not pertaining to this grant
- Access Criteria
- Individual participant data will not be shared due to the regulation not pertaining to this grant
Data will be disseminated using multiple strategies, such as making our results available to the NIH ClinicalTrials.gov website, transmitting them to the aging research community through peer-reviewed journals, and giving presentations of the results of the study at national and international scientific meetings. Additionally, presentations will be given to the local African American community to churches, Alzheimer's disease support groups, and beauty salons.